Question 1

What is the catalog number for OVA Conjugated Procollagen II C-Terminal Propeptide (PIICP)?

Accepted Answer

The catalog number for OVA Conjugated Procollagen II C-Terminal Propeptide (PIICP) is SDPA286Hu21.

Question 2

What sizes are available for OVA Conjugated Procollagen II C-Terminal Propeptide (PIICP)?

Accepted Answer

OVA Conjugated Procollagen II C-Terminal Propeptide (PIICP) is available in the following size(s): 10 µg, 50 µg, 200 µg, 1 mg, 5 mg.

Question 3

How many pack sizes does OVA Conjugated Procollagen II C-Terminal Propeptide (PIICP) come in?

Accepted Answer

OVA Conjugated Procollagen II C-Terminal Propeptide (PIICP) is available in 5 different pack sizes.

Question 4

Is OVA Conjugated Procollagen II C-Terminal Propeptide (PIICP) in stock?

Accepted Answer

OVA Conjugated Procollagen II C-Terminal Propeptide (PIICP) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 6

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 7

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

OVA Conjugated Procollagen II C-Terminal Propeptide (PIICP)

Product Specifications

Gene Aliases

Organism

Source

Applications

Purity

Species

Available Sizes

Frequently Asked Questions

Explore Other Products

CD45RA (PTPRC/1131), 1mg/mL

HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), Biotin conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL

CD70 (TNFS7/1026), CF568 conjugate, 0.1mg/mL

NRF1 (NRF1/2609), CF488A conjugate, 0.1mg/mL

Tyrosinase (OCA1/812), CF405S conjugate, 0.1mg/mL